• OPEN AN ACCOUNT
Indian Indices
Nifty
26,046.95 148.40
(0.57%)
Sensex
85,267.66 449.53
( 0.53%)
Bank Nifty
59,389.95 180.10
( 0.30%)
Nifty IT
38,274.75 177.75
( 0.47%)
Global Indices
Nasdaq
48,475.79 -249.23
(-0.51%)
Dow Jones
6,848.05 -73.95
(-1.07%)
Hang Seng
50,843.93 695.11
(1.39%)
Nikkei 225
9,668.36 -34.80
(-0.36%)
Forex
USD-INR
90.19 0.30
(0.34%)
EUR-INR
105.70 1.00
(0.96%)
GBP-INR
120.75 0.96
(0.80%)
JPY-INR
0.58 0.01
(0.91%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
62.6776943
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
64.1
3483.81
EPS(TTM)
Face Value()
Div & Yield %
5.42
1
0.03
 

Newgen Software bags Rs 14-cr order from Mercedes-Benz Financial Services India
Dec 04,2025
The contract is to be executed over a period of five years from the date of license supply.

Newgen Software Technologies is a global software company and is engaged in the business of software product development, including designing and delivering end-to-end software solutions covering the entire spectrum of software services from workflow automation to document management to imaging.

The company reported a 16.2% jump in consolidated net profit to Rs 81.7 crore on an 11% increase in revenue from operations to Rs 400.8 crore in Q2 FY26 over Q2 FY25.

Shares of Newgen Software Technologies rose 0.75% to Rs 886 on the BSE.